HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Making “Value” About More Than Price Drives Natural Products Growth

This article was originally published in The Tan Sheet

Executive Summary

Consumers’ expanding view of “value” is one key factor that will help increase sales in the natural products industry an estimated 50% to $226 billion by 2018, market researchers say. Value-shoppers are moving beyond price as a purchasing filter to include convenience, ingredient quality and social consciousness.

You may also be interested in...



Fortitech Deal Fills Gap In DSM’s Nutritional Portfolio

DSM’s announcement of its $634 million cash acquisition of Fortitech follows the firm’s report that its nutritional business was the key sales driver in its latest earnings period. Fortitech adds macro-blend manufacturing for human nutritional products to DSM’s supply chain.

Gaia Hopes Meet Your Herbs Traceability Meets With Greater Sales, Trust

Gaia Herbs looks to grow both sales and consumer trust by offering online access to supply chain information that attests to its botanical supplement products' purity

J&J Consumer Sales Slip Even As Recalled Brands, Seasonal Items Reach Stores

J&J reports worldwide consumer sales dipped 0.6% to $3.6 billion despite retailers buying more upper respiratory and analgesic products to prepare for the cough and cold season. But in key OTC categories the firm is regaining market share it lost when its iconic brands were temporarily not available.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS123961

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel